HomeALGS • NASDAQ
add
Aligos Therapeutics Inc
Previous close
$5.80
Day range
$5.57 - $6.08
Year range
$3.76 - $46.80
Market cap
35.71M USD
Avg Volume
190.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 311.00K | -68.46% |
Operating expense | 5.05M | -24.21% |
Net income | 43.09M | 223.59% |
Net profit margin | 13.85K | 491.84% |
Earnings per share | 5.12 | 193.09% |
EBITDA | -19.05M | 12.47% |
Effective tax rate | 0.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 137.86M | 22.28% |
Total assets | 150.70M | 17.82% |
Total liabilities | 34.25M | -49.70% |
Total equity | 116.44M | — |
Shares outstanding | 6.11M | — |
Price to book | 0.30 | — |
Return on assets | -43.58% | — |
Return on capital | -92.76% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 43.09M | 223.59% |
Cash from operations | -20.91M | 8.08% |
Cash from investing | -44.07M | 50.29% |
Cash from financing | 101.74M | 535,584.21% |
Net change in cash | 36.77M | 133.00% |
Free cash flow | -13.88M | 12.85% |
About
Founded
2018
Headquarters
Website
Employees
70
